Leads Biolabs Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Public

  • Employees
  • 259

Employees

  • Stock Symbol
  • 09887

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $4.48
  • (As of Friday Closing)

Leads Biolabs General Information

Description

Nanjing Leads Biolabs Co Ltd is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of new therapies in oncology, autoimmune, and other severe diseases. The Group uses its science-driven R&D approach and three proprietary technology platforms: X-body (4-1BB Engager), LeadsBody (CD3 T Cell Engager), and TOPiKinectics (ADC), for its multi-modal, differentiated pipeline in oncology and autoimmune diseases. It has approximately fourteen drug candidates across oncology and autoimmune diseases. Among these, one core product (LBL-024, a pivotal-stage PD-L1 and 4-1BB dual-targeting bispecific antibody) is being evaluated in several cancer indications and across various Proof-of-Concept (POC) studies. The Group generates maximum revenue from the USA.

Contact Information

Website
leadsbiolabs.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Floor 8, Building 03
  • 18E, Jialingjiang Street
  • Nanjing, Jiangsu 210019
  • China
+86 025
Primary Industry
Drug Discovery
Stock Exchange
HKG
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Floor 8, Building 03
  • 18E, Jialingjiang Street
  • Nanjing, Jiangsu 210019
  • China
+86 025

Leads Biolabs Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Leads Biolabs Stock Performance

As of 13-Nov-2026, Leads Biolabs’s stock price is $4.48. Its current market cap is $874M with 195M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.48 $4.78 $4.29 - $12.45 $874M 195M 1.55M -$0.21

Leads Biolabs Financials Summary

As of 30-Jun-2026, Leads Biolabs has a trailing 12-month revenue of $30.5M.

In Thousands,
USD 		TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,071,267 1,244,320
Revenue 30,472 24,648 0 1,253
EBITDA (38,302) (27,402) (38,701) (48,550)
Net Income (38,151) (29,399) (41,979) (51,202)
Total Assets 226,511 254,608 91,703 63,127
Total Debt 54,956 40,099 36,503 9,464
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Leads Biolabs Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Leads Biolabs‘s full profile, request access.

Request a free trial

Leads Biolabs Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Leads Biolabs Investments (1)

Leads Biolabs’s most recent deal was a Joint Venture with Oblenio Bio. The deal was made on 07-Nov-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Oblenio Bio 07-Nov-2024 Joint Venture Biotechnology
To view Leads Biolabs’s complete investments history, request access »

Leads Biolabs ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Leads Biolabs’s complete esg history, request access »

Leads Biolabs FAQs

  • When was Leads Biolabs founded?

    Leads Biolabs was founded in 2012.

  • Where is Leads Biolabs headquartered?

    Leads Biolabs is headquartered in Nanjing, China.

  • What is the size of Leads Biolabs?

    Leads Biolabs has 259 total employees.

  • What industry is Leads Biolabs in?

    Leads Biolabs’s primary industry is Drug Discovery.

  • Is Leads Biolabs a private or public company?

    Leads Biolabs is a Public company.

  • What is Leads Biolabs’s stock symbol?

    The ticker symbol for Leads Biolabs is 09887.

  • What is the current stock price of Leads Biolabs?

    As of 13-Nov-2026 the stock price of Leads Biolabs is $4.48.

  • What is the current market cap of Leads Biolabs?

    The current market capitalization of Leads Biolabs is $874M.

  • What is Leads Biolabs’s current revenue?

    The trailing twelve month revenue for Leads Biolabs is $30.5M.

  • What is Leads Biolabs’s annual earnings per share (EPS)?

    Leads Biolabs’s EPS for 12 months was -$0.21.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process